Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R C Bast

Showing results (191-200 of 299) with videos related to

Pageof 30
Sort By:
Lancet (London, England)|August 25, 1984
Anti-B1 monoclonal antibody and complement treatment in autologous bone-marrow transplantation for relapsed B-cell non-Hodgkin's lymphomaL M Nadler, T Takvorian, L Botnick, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|November 5, 1997
Improving physician-patient communication in cancer care: outcome of a workshop for oncologistsW F Baile, R Lenzi, A P Kudelka, et al.
Journal of the National Cancer Institute|February 1, 1980
Specificity of heteroantisera developed against purified populations of intact murine ovarian carcinoma cellsR C Bast, R C Knapp, V C Donahue, et al.
Journal of the National Cancer Institute|March 2, 1994
Overexpression of the protein tyrosine phosphatase PTP1B in human breast cancer: association with p185c-erbB-2 protein expressionJ R Wiener, B J Kerns, E L Harvey, et al.
Obstetrics and Gynecology|May 1, 1986
CA 125 serum levels correlated with second-look operations among ovarian cancer patientsJ S Berek, R C Knapp, G D Malkasian, et al.
Clinical Chemistry|May 1, 1999
OVX1 radioimmunoassay results are dependent on the method of sample collection and storageE V Hogdall, C K Hogdall, S K Kjaer, et al.
International Journal of Cancer|December 5, 2000
Predictive values of serum tumour markers tetranectin, OVX1, CASA and CA125 in patients with a pelvic massE V Hogdall, C K Høgdall, S Tingulstad, et al.
American Journal of Obstetrics and Gynecology|November 1, 1989
Epidermal growth factor receptor expression in normal and malignant endometriumA Berchuck, A P Soisson, G J Olt, et al.
American Journal of Obstetrics and Gynecology|November 1, 1989
Immunohistochemical expression of TAG-72 in normal and malignant endometrium: correlation of antigen expression with estrogen receptor and progesterone receptor levelsA P Soisson, A Berchuck, B A Lessey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1988
High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancerW P Peters, E J Shpall, R B Jones, et al.
Pageof 30

Showing results (191-200 of 299) with videos related to

Sort By:
Pageof 30
Lancet (London, England)|August 25, 1984
Anti-B1 monoclonal antibody and complement treatment in autologous bone-marrow transplantation for relapsed B-cell non-Hodgkin's lymphomaL M Nadler, T Takvorian, L Botnick, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|November 5, 1997
Improving physician-patient communication in cancer care: outcome of a workshop for oncologistsW F Baile, R Lenzi, A P Kudelka, et al.
Journal of the National Cancer Institute|February 1, 1980
Specificity of heteroantisera developed against purified populations of intact murine ovarian carcinoma cellsR C Bast, R C Knapp, V C Donahue, et al.
Journal of the National Cancer Institute|March 2, 1994
Overexpression of the protein tyrosine phosphatase PTP1B in human breast cancer: association with p185c-erbB-2 protein expressionJ R Wiener, B J Kerns, E L Harvey, et al.
Obstetrics and Gynecology|May 1, 1986
CA 125 serum levels correlated with second-look operations among ovarian cancer patientsJ S Berek, R C Knapp, G D Malkasian, et al.
Clinical Chemistry|May 1, 1999
OVX1 radioimmunoassay results are dependent on the method of sample collection and storageE V Hogdall, C K Hogdall, S K Kjaer, et al.
International Journal of Cancer|December 5, 2000
Predictive values of serum tumour markers tetranectin, OVX1, CASA and CA125 in patients with a pelvic massE V Hogdall, C K Høgdall, S Tingulstad, et al.
American Journal of Obstetrics and Gynecology|November 1, 1989
Epidermal growth factor receptor expression in normal and malignant endometriumA Berchuck, A P Soisson, G J Olt, et al.
American Journal of Obstetrics and Gynecology|November 1, 1989
Immunohistochemical expression of TAG-72 in normal and malignant endometrium: correlation of antigen expression with estrogen receptor and progesterone receptor levelsA P Soisson, A Berchuck, B A Lessey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1988
High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancerW P Peters, E J Shpall, R B Jones, et al.
Pageof 30